Compile Data Set for Download or QSAR
Report error Found 113 Enz. Inhib. hit(s) with Target = 'Hsp90 chaperone protein kinase-targeting subunit'
TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551777(US11312722, Compound 67)
Affinity DataEC50:  18nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551762(US11312722, Compound 52)
Affinity DataEC50:  21nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551755(US11312722, Compound 45)
Affinity DataEC50:  22nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551758(US11312722, Compound 48)
Affinity DataEC50:  23nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551761(US11312722, Compound 51)
Affinity DataEC50:  23nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551757(US11312722, Compound 47)
Affinity DataEC50:  25nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551756(US11312722, Compound 46)
Affinity DataEC50:  25nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551776(US11312722, Compound 66)
Affinity DataEC50:  26nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551760(US11312722, Compound 50)
Affinity DataEC50:  26nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551783(US11312722, Compound 73)
Affinity DataEC50:  35nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551795(US11312722, Compound 85)
Affinity DataEC50:  36nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551786(US11312722, Compound 76)
Affinity DataEC50:  36nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551780(US11312722, Compound 70)
Affinity DataEC50:  37nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551815(US11312722, Compound 105)
Affinity DataEC50:  37nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551764(US11312722, Compound 54)
Affinity DataEC50:  39nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551730(US11312722, Compound 20)
Affinity DataEC50:  40nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551794(US11312722, Compound 84)
Affinity DataEC50:  40nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551812(US11312722, Compound 102)
Affinity DataEC50:  40nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551765(US11312722, Compound 55)
Affinity DataEC50:  40nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551774(US11312722, Compound 64)
Affinity DataEC50:  41nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551763(US11312722, Compound 53)
Affinity DataEC50:  41nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551785(US11312722, Compound 75)
Affinity DataEC50:  43nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551793(US11312722, Compound 83)
Affinity DataEC50:  44nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551779(US11312722, Compound 69)
Affinity DataEC50:  44nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551782(US11312722, Compound 72)
Affinity DataEC50:  45nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551797(US11312722, Compound 87)
Affinity DataEC50:  48nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551775(US11312722, Compound 65)
Affinity DataEC50:  51nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551784(US11312722, Compound 74)
Affinity DataEC50:  52nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551792(US11312722, Compound 82)
Affinity DataEC50:  58nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551787(US11312722, Compound 77)
Affinity DataEC50:  58nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551778(US11312722, Compound 68)
Affinity DataEC50:  61nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551811(US11312722, Compound 101)
Affinity DataEC50:  62nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551772(US11312722, Compound 62)
Affinity DataEC50:  62nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551796(US11312722, Compound 86)
Affinity DataEC50:  63nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551734(US11312722, Compound 24)
Affinity DataEC50:  63nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551816(US11312722, Compound 106)
Affinity DataEC50:  65nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551803(US11312722, Compound 93)
Affinity DataEC50:  66nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551750(US11312722, Compound 40)
Affinity DataEC50:  72nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551790(US11312722, Compound 80)
Affinity DataEC50:  74nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551801(US11312722, Compound 91)
Affinity DataEC50:  78nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551818(US11312722, Compound 108)
Affinity DataEC50:  84nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551744(US11312722, Compound 34)
Affinity DataEC50:  86nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551732(US11312722, Compound 22)
Affinity DataEC50:  87nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551810(US11312722, Compound 100)
Affinity DataEC50:  87nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551781(US11312722, Compound 71)
Affinity DataEC50:  87nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551766(US11312722, Compound 56)
Affinity DataEC50:  88nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551745(US11312722, Compound 35)
Affinity DataEC50:  91nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551751(US11312722, Compound 41)
Affinity DataEC50:  94nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551742(US11312722, Compound 32)
Affinity DataEC50:  96nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

TargetHsp90 chaperone protein kinase-targeting subunit(Cryptococcus neoformans var. neoformans serotype D...)
Trustees of Boston University

US Patent
LigandPNGBDBM551771(US11312722, Compound 61)
Affinity DataEC50:  97nMAssay Description:EC50 values were determined by FP-based equilibrium competition assay performed in 384-well format using whole cell lysates prepared from C. neoforma...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2022
Entry Details
US Patent

Displayed 1 to 50 (of 113 total ) | Next | Last >>
Jump to: